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Abstract
Background: The global phenomenon of population ageing is creating new challenges in both high and middle
income countries, as functional limitations are expected to increase with age. The attribution method has been
proposed to identify which conditions contribute most to disability using cross-sectional data. Although the
original method was based on binary outcomes, we recently proposed an extension to multinomial responses,
since different disability levels are often investigated in surveys. This is the first application of the extended method to
evaluate differences in the contribution of chronic conditions to functional limitations in the older population of Brazil
and Belgium.
Methods: Representative data from individuals aged ≥65 years who participated in the 2008 or 2013 Health Interview
Surveys in Belgium (N = 4521) or in the 2008 National Household Sample Survey in Brazil (N = 28,437) were analysed.
Individuals were classified as without, moderate or severe functional limitations, based on three activities of daily living:
eating, showering, and toileting. Six chronic conditions common to the surveys – diabetes, heart diseases, musculoskeletal
conditions, depression, chronic respiratory diseases, and cancer – were included in the analysis. Separate multinomial
additive hazards models by gender for each country were fitted.
Results: The prevalence of moderate functional limitations was larger in men in Brazil (8.4%) compared to Belgium (6.0%)
and similar in women (approximately 12.0%). Conversely, the severe prevalence in men was similar in the two
countries (around 8.0%) and higher in women from Belgium (16.6%) than from Brazil (9.1%). Musculoskeletal conditions
were the main contributors to the prevalence of functional limitations in men and women in Belgium but only in men
and women with moderate functional limitations in Brazil. Depression and heart diseases contributed most to the
severe prevalence of functional limitations in men and women in Brazil, respectively.
Conclusions: Our findings provide a better understanding of differences in the prevalence of different levels of
functional limitations in Brazil and Belgium. These differences can be related to differences in socioeconomic conditions,
health care access and quality, disease diagnosis, stage of epidemiology transition, life expectancy, and the prevalence of
lifestyle risk factors in the two countries.
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Background
Although population ageing is currently considered a global
phenomenon, the burden of chronic conditions and func-
tional limitations, common at older ages, have different
impacts in high and middle income countries [1, 2].
While in low and middle income countries the increase
in the proportion of older individuals is related to the
fast reduction of fertility rates and infant mortality,
especially from infectious diseases, in high income
countries this is currently a result of the decrease in
mortality at older ages [2, 3]. One key difference in the
increased life expectancy observed in developed and
developing countries is the pace in which this process
is developing: whilst it started more than a century ago
in most developed countries, it is a recent phenomenon
in developing countries [4]. This rapid ageing process
poses challenges in developing countries as they did
not grow wealth before growing old [5]. As a conse-
quence, health care systems of less developed countries
are less prepared to provide appropriate long-term care
to older individuals [6, 7].
Limitations in activity of daily living (ADL) can
represent difficulty or dependence in self-care [8],
indicating that older individuals with functional limi-
tations are a heterogeneous group. The assessment
of different levels of functional limitations is funda-
mental to better understand differences in the needs
and demands of older individuals, as dependency
levels are associated with higher demand for long
term care and mortality [9, 10].
Information on how much different chronic conditions
contribute to different levels of functional limitations is
crucial to develop public health strategies aiming to re-
duce function loss. This can be assessed with the attribu-
tion method [11, 12], in which cross-sectional data are
used to estimate the prevalence of functional limitations.
The prevalence of functional limitations is then parti-
tioned into the additive contribution of diseases, taking
into account that individuals can report more than one
disease (multimorbidity) and that functional limitations
can occur in the absence of disease. The attribution
method was originally developed for binary outcomes
[11, 12], but it was recently extended to allow multicate-
gory responses [13]. Although the original attribution
method has been previously used to investigate the dis-
ability burden in Belgium [14–18] and in Brazil [19]
using binary outcomes, this is the first study to compare
the contributions in a high and middle income country
using a multinomial outcome for functional limitations,
representing different severity levels.
Thus, the aim of this study was to assess the main
contributors to moderate and severe functional limi-
tations in the older population from Belgium and in
Brazil.
Methods
Surveys and study populations
This study focused on Belgium and Brazil due to the data
availability of independent, population-based, national sur-
veys with similar questions about functional limitations and
chronic conditions. The prevalence of risk factors for
chronic conditions and the risk of premature mortality due
to selected chronic conditions (cancer, diabetes, cardiovas-
cular diseases, and chronic respiratory diseases) in both
countries were very similar to the aggregated estimates of
high and upper-middle income countries (Additional file 1),
suggesting that these two countries are good representa-
tives of the latter groups.
Data from the following national health surveys
from Belgium and Brazil were used: (i) Health Interview
Surveys conducted in Belgium (HISBe) in 2008 and 2013;
and (ii) National Household Sample Survey conducted in
Brazil (NHSSBr) in 2008. A summary of the main char-
acteristics of each survey is presented in Table 1. Al-
though the surveys allowed proxy interviews, the
NHSSBr excluded individuals living in nursing homes or
homes for the elderly. The response rate in the Brazilian
survey (95%) was greater than in the Belgian surveys
(2008 = 55%; 2013 = 57%). The HISBe data are
available upon request and approval to the Belgian
Privacy Commission <https://his.wiv-isp.be/SitePages/Ac
ces_microdata.aspx> and the NHSSBr is openly available
at <http://www.ibge.gov.br/home/estatistica/populacao/
trabalhoerendimento/pnad2011/microdados.shtm>. More
details about the HISBe [20] and the NHSSBr [21] meth-
odologies can be found elsewhere.
Here, we focused on the population aged 65 years or
older, as functional limitations and chronic conditions
are more frequent at older ages [15]. For Belgium, the
data of the 2008 and 2013 surveys were pooled due to
the small sample size of the 2008 HISBe, which did not
allow fitting the multinomial model stratified by age and
gender. Nonetheless, the prevalence of moderate and se-
vere functional limitations was similar in the two Belgian
surveys for most age groups (Additional file 2).
In total, 4521 (HISBe) and 28,437 (NHSSBr) individuals
were included in this study, respectively. For comparability
purposes, the questions used to define functional limita-
tions and the chronic conditions included in this analysis
were common to the surveys in both countries.
Functional limitations were defined based on limitations
in three activities of daily living (ADL): eating, showering,
and toileting (Table 1). These three ADLs cover the whole
ADL spectrum: eating is considered the easiest task, which
is generally lost late in life; toileting is an intermediate task,
with middle loss; and bathing is a difficult task, with an
early loss [22–24]. The multicategory outcome was defined
as “0. No functional limitations”, for individuals who
answered “No difficulty”; “1. Moderate functional
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limitations”, for individuals who responded “Some
difficulty”; and “2. Severe functional limitations”, for indi-
viduals who answered “A lot of difficulty” or “Unable” in
the NHSSBr or “A lot of difficulty” or “Can’t achieve it by
myself” in the HISBe. The last response options were
grouped due to sparseness.
Six chronic conditions were considered in the present
analysis: diabetes, heart diseases (myocardial infarction
and coronary heart diseases), chronic respiratory dis-
eases (HISBe: asthma, chronic bronchitis, pulmonary
emphysema, chronic obstructive pulmonary diseases
(COPD); NHSSBr: asthma and chronic bronchitis);
musculoskeletal conditions (arthritis and back pain),
depression, and cancer.
Statistical analysis
To improve comparability between the two countries, age
and gender standardized disease prevalence is presented,
based on direct standardization [25], with the world popu-
lation used as standard.
The attribution method [11, 12] was used to estimate
the contribution of chronic conditions to the prevalence of
functional limitations, taking into account multimorbidity
and that functional limitations can be present even in the
absence of diseases. In individuals with functional limita-
tions who did not report any of the considered diseases,
functional limitations are attributed to “background”,
while in individuals who reported diseases, functional
limitations are partitioned into “background” and diseases.
The background can represent the effect of age-related
losses in functioning, functional limitations that are not
associated with any disease (e.g. the environment), causes
of functional limitations not included in the survey, and
underreported or underdiagnosed diseases. More informa-
tion about the attribution method can be found in previ-
ous publications [11, 12].
Table 1 – Characteristics of the Health Interview Surveys, Belgium, 2008 and 2013 and National Household Sample Survey, Brazil, 2008
Characteristic Belgium Brazil
Survey year 2008 2013 2008
Sample size 11,254 10,829 391,868
Respondents aged ≥65 years with complete data 2503 2018 28,437
Response rate 55% 57% 95%
Sampling frame National Population Register 2000 census
Sampling design Multistage with stratification (regions and
provinces), and clustering (municipality
and household)
Multistage with simple random sampling
(self-representative municipalities), stratification
(non-representative municipalities and census
tracts), and clustering (households)
Target population Belgian population, including individuals
living in nursing homes or homes for the
elderly
Brazilian population
Excluded subgroups Homeless and illegal immigrants not
included in the sampling frame and
individuals living in prisons or religious
communities with more than 8 residents
Military bases, prisons, homes for the elderly,
homes for the children, monasteries, and
hospitals
Proxy interview Mandatory for individuals aged <15 years;
allowed for individuals with severe mental
or physical conditions not able to respond
to the interview and individuals who refused
to participate, but allowed proxy answers
Allowed
Question for chronic conditions During the past 12 months, have you had
any of the following diseases or conditions?
Has a doctor or health professional said that
you have (disease/condition)?
Question for ADL limitations Do you usually have difficulty in doing any
of these activities by yourself? (Activities
included in this analysis: feeding yourself,
bathing or showering, and using toilets)
In general, because of a health problem, do
you have difficulty to eat, take a shower, or
go to the
toilet?
Response options for ADL limitations questions 1. No difficulty
2. Yes, some difficulty
3. Yes, a lot of difficulty
4. I can’t achieve it by myself
1. Unable
2. A lot of difficulty
3. Some difficulty
4. No difficulty
Interview method for ADL limitations and chronic
condition questions
Face-to-face interview Face-to-face interview
ADL limitations: activities of daily living limitations
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Here, the extended attribution method was used, allow-
ing multicategory responses. This extension is based on
the multinomial additive hazard model [13], defined as:
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where y(1,…, j) is the observed multicategory outcome for
functional limitations, with y1 defined as the reference cat-
egory (no functional limitations), y2 as moderate functional
limitations and y3 as severe functional limitations; yj
∧
is the
estimated probability for functional limitation level j; ηj is
the linear predictor representing the overall cumulative
hazard of functional limitation level j; αaj is the cumulative
hazard of functional limitation level j for background by
age group a(65–74 years; ≥75 years); βadj is the cumulative
hazard of functional limitation level j for disease d(1,…,m)
and age group a, also known as the disabling impact of dis-
ease [11, 12]; Xa is the indicator variable for each age group
a; and Xd is the indicator variable for each disease d. To
estimate the model parameters (αaj and βadj) constrained
optimization [26] was used.
In the model above, the attribution of functional limita-
tions to diseases depends on the disease prevalence by age
group (XaXd) and the disabling impacts of the diseases
(βadj) [11, 12]. The contribution of diseases and back-
ground to the moderate and severe prevalence of func-
tional limitations was obtained in three steps [13]:
1. Similar to the competing risks analysis, the
proportionality assumption [27] was used to
estimate the disease-specific probability of moderate
(j = 2) and severe (j = 3) functional limitations,
D^dj ¼
βadjXaXd
ηj
 y^j, and for the background,
B^j ¼ αajηj  y^j, for each individual;
2. Next, the number of individuals with moderate
(j = 2) and severe (j = 3) functional limitations by
each disease, N^dj ¼
Pn
i¼1D^dj, and by background,
N^bj ¼
Pn
i¼1B^j , are obtained by the sum of cause-
specific probabilities in the population studied;
3. The absolute contribution to the moderate (j = 2) and
severe (j = 3) prevalence of functional limitations (A^Cj)
of each disease ( ^ACdj ¼
N^dj
n  100) and background
( ^ACbj ¼
N^bj
n  100), i.e. the prevalence of moderate
and severe functional limitations by cause, is
estimated by dividing the total number of
individuals with moderate and severe functional
limitations for each cause by the total number of
individuals in the population studied.
The absolute contributions and the moderate and severe
prevalence of functional limitations for Belgium and Brazil
were age-standardized, using direct standardization [25]
and the world population as standard. The confidence in-
tervals for the disease prevalence and the disabling impacts
were obtained via bootstrapping [28]. All the analysis were
carried out in R [29]. The multinomial additive hazard
model was fitted with the R package “addhaz” [30].
Results
Table 2 shows the characteristics of the study population
of each country. Although the age distribution of indi-
viduals without functional limitations is similar between
the countries, a higher proportion of older individuals is
observed in the Belgian population with moderate and
severe functional limitations compared to Brazil. The
proportion of lower educated men and women in Brazil
was much larger than in Belgium across all subgroups.
The proportion of men and women who did not report
any selected chronic conditions was similar among men
and women without functional limitations in the two
countries, but higher in Brazilian men and women with
moderate and severe functional limitations compared to
Belgium. The proportion of multimorbidity (≥2 selected
chronic conditions) was similar in the male population
from Belgium and Brazil and higher in women
from Brazil than in women from Belgium.
Musculoskeletal conditions (back pain and arthritis)
were the most common chronic conditions in Belgium
and Brazil, while cancer was the least frequent condition
in both countries (Fig. 1). The prevalence of musculo-
skeletal conditions (Brazil: 44.8%, 95% CI: 44.3%–45.4%;
Belgium: 50.5%, 95% CI: 48.0%–53.0%), chronic respira-
tory conditions (Brazil: 6.2%, 95% CI: 5.4%–7.1%; Belgium:
10.0%, 95% CI: 8.8%–11.4%), and cancer (Brazil: 2.7%,
95% CI: 2.4%–3.2%; Belgium: 5.7%, 95% CI: 4.6%–7.0%)
was higher in Belgium than in Brazil, whilst the preva-
lence of diabetes (Brazil: 16.3%, 95% CI: 15.4%; 17.2%;
Belgium: 12.3%, 95% CI: 10.8%; 14.1%) and heart dis-
eases (Brazil: 18.9%, 95% CI: 16.7%; 21.3%; Belgium:
6.2%, 95% CI: 5.1%; 7.5%) was higher in Brazil than in
Belgium (Fig. 1).
Tables 3 and 4 show the disabling impacts and the
background cumulative hazards for men and women, re-
spectively. In Belgium, depression and cancer were the
most disabling diseases in men aged 65–74 years and
75 years or older with moderate functional limitations,
respectively, whereas chronic respiratory diseases showed
the highest impact in men with severe functional limita-
tions. In Brazil, depression was the most disabling condition
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for men with moderate and severe functional limitations
across all age groups (Table 3).
Depression was the most disabling condition for Belgian
women with moderate functional limitations, whilst can-
cer and depression showed the highest impact on severe
functional limitations in women aged 65–74 years and
≥75 years, respectively.
In Brazil, cancer was the most disabling disease for
women aged 65–74 years with moderate or severe func-
tional limitations, whereas heart diseases and depression
Table 2 Characteristics of the study population. Health Interview Surveys, Belgium, 2008 and 2013 and National Household Sample
Survey, Brazil, 2008
Characteristic Men
Belgium Brazil
No limitations Moderate Severe No limitations Moderate Severe
N %a N %a N %a N %a N %a N %a
Age group (years)
65–69 465 33.8 19 17.5 15 8.0 4143 39.5 233 23.5 206 21.8
70–74 351 27.7 15 12.2 21 15.5 2879 28.6 234 24.2 179 18.5
75–79 291 19.7 28 19.3 45 19.7 1803 17.7 202 21.9 200 21.3
80–84 206 13.5 40 33.0 43 27.2 914 8.8 144 15.0 168 18.9
≥ 85 206 5.3 63 18.0 132 29.6 543 5.3 145 15.3 185 19.5
Education level
No diploma/primary 407 26.8 55 36.6 113 50.8 7943 77.7 830 87.5 786 84.6
Secondary 678 47.9 74 45.9 93 35.9 750 6.9 53 5.0 45 4.8
Tertiary 407 24.2 32 16.4 38 12.2 1589 15.4 75 7.5 107 10.6
Missing information 27 1.5 4 1.1 12 1.1 0 0 0 0 0 0
Number of chronic conditionsb
0 671 44.7 48 21.2 51 20.2 4635 44.8 245 26.4 235 26.1
1 547 36.5 58 35.0 96 33.1 3796 36.9 376 39.2 321 34.0
≥ 2 263 16.1 50 40.3 95 42.9 1851 18.3 337 34.4 382 39.9
Missing information 38 2.7 9 3.5 14 3.9 0 0 0 0 0 0
Women
Age group (years)
65–69 481 29.9 38 14.4 18 5.3 4977 38.3 416 23.1 224 15.1
70–74 389 27.7 42 17.9 48 10.2 3487 27.1 427 23.1 248 16.4
75–79 338 19.9 56 23.2 83 16.1 2363 18.3 395 21.7 303 19.0
80–84 260 15.2 66 24.0 149 31.7 1327 10.4 283 16.7 328 21.8
≥ 85 334 7.3 137 20.4 467 36.7 759 5.9 281 15.4 441 27.7
Education level
No diploma/primary 590 31.7 139 44.3 392 58.3 10,196 79.6 1582 88.4 1362 88.7
Secondary 853 51.1 144 42.7 241 30.8 988 7.6 93 4.9 76 4.6
Tertiary 328 16.0 43 11.6 48 5.0 1720 12.6 126 6.7 106 6.7
Missing information 31 1.2 13 1.4 84 5.8 9 0.1 1 0.1 0 0
Number of chronic conditionsb
0 664 36.7 77 18.8 151 15.7 4466 34.8 372 21.8 310 19.9
1 744 41.2 142 40.7 307 40.3 5079 38.7 691 37.8 517 32.4
≥ 2 338 19.3 99 36.4 261 38.5 3368 26.5 739 40.4 717 47.7
Missing information 56 2.8 21 4.1 46 5.6 0 0 0 0 0 0
aWeighted prevalence is presented
bChronic conditions considered: diabetes, heart diseases, chronic respiratory diseases, musculoskeletal conditions, depression, and cancer
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Fig. 1 – Age and gender standardized disease prevalence. Health Interview Surveys, Belgium, 2008 and 2013 and National Household Sample
Survey, Brazil, 2008. Heart diseases: myocardial infarction and coronary heart disease.Musculoskeletal: arthritis and back pain. Respiratory: asthma
and chronic bronchitis (Brazil); and asthma, chronic bronchitis, pulmonary emphysema, chronic obstructive pulmonary diseases (Belgium). Direct
standardization used with the world population as standard
Table 3 Background cumulative hazard and rank of the disabling impact by age group for men. Health Interview Surveys, Belgium,
2008 and 2013 and National Household Sample Survey, Brazil, 2008
Belgium
Rank Moderate Severe
65–74 years ≥75 years 65–74 years ≥75 years
Condition DI CI Condition DI CI Condition DI CI Condition DI CI
1 Depression 0.19 −0.01; 0.65 Cancer 0.15 −0.04; 0.45 Respiratory 0.12 0.02; 2.82 Respiratory 0.17 0.02; 0.36
2 Respiratory 0.08 0.00; 0.20 Depression 0.07 −0.07; 0.43 Depression 0.12 −0.18; 4.42 Musculoskeletal 0.14 0.06; 0.23
3 Diabetes 0.04 −0.01; 0.10 Musculoskeletal 0.06 0.00; 0.12 Cancer 0.03 −0.33; 0.60 Diabetes 0.10 −0.01; 0.26
4 Musculoskeletal 0.01 −0.01; 0.03 Diabetes 0.05 −0.05; 0.18 Heart diseases 0.02 −0.48; 1.24 Depression 0.10 −0.07; 0.51
5 Cancer 0.01 −0.01; 0.12 Heart diseases 0.04 −0.04; 0.15 Musculoskeletal 0.00 −0.03; 0.04 Heart diseases 0.09 −0.05; 0.25
6 Heart diseases 0.00 −0.02; 0.11 Respiratory 0.04 −0.05; 0.16 Diabetes 0.00 −3.46; 0.07 Cancer 0.00 −0.12; 0.18
– Background 0.01 0.00; 0.02 Background 0.06 0.04; 0.10 Background 0.02 0.00; 0.05 Background 0.08 0.05; 0.12
Brazil
Rank Moderate Severe
65–74 years ≥75 years 65–74 years ≥75 years
Condition DI CI Condition DI CI Condition DI CI Condition DI CI
1 Depression 0.10 0.06; 0.15 Background 0.09 0.08; 0.11 Depression 0.10 0.06; 0.15 Depression 0.33 0.22; 0.46
2 Cancer 0.07 0.02; 0.11 Depression 0.07 0.00; 0.14 Cancer 0.07 0.02; 0.12 Cancer 0.17 0.08; 0.27
3 Musculoskeletal 0.04 0.03; 0.05 Musculoskeletal 0.06 0.03; 0.09 Diabetes 0.03 0.01; 0.05 Diabetes 0.09 0.05; 0.14
4 Heart diseases 0.03 0.01; 0.05 Heart diseases 0.05 0.02; 0.08 Heart diseases 0.03 0.02; 0.05 Respiratory 0.09 0.03; 0.17
5 Respiratory 0.03 0.00; 0.07 Respiratory 0.04 −0.02; 0.10 Respiratory 0.02 −0.01; 0.05 Heart diseases 0.06 0.03; 0.10
6 Diabetes 0.01 0.00; 0.03 Diabetes 0.02 −0.02; 0.06 Musculoskeletal 0.01 0.00; 0.02 Musculoskeletal 0.03 0.00; 0.05
– Background 0.03 0.03; 0.04 Background 0.09 0.08; 0.11 Background 0.03 0.02; 0.04 Background 0.08 0.07; 0.10
Heart diseases: myocardial infarction and coronary heart disease
Musculoskeletal: arthritis and back pain
Respiratory: asthma and chronic bronchitis (Brazil); and asthma, chronic bronchitis, pulmonary emphysema, and chronic obstructive pulmonary
diseases (Belgium)
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showed the highest impact in women aged 75 years or
older with moderate and severe functional limitations,
respectively (Table 4).
The age-standardized prevalence of functional limitations
and absolute contribution of chronic conditions to moder-
ate and severe functional limitations in Belgium and Brazil
is shown in Fig. 2 and in Additional file 3. Both moderate
and severe functional limitations were more common in
women compared to men in both countries (Fig. 2). While
the moderate prevalence of functional limitations was lar-
ger in men from Brazil (8.4%) compared to Belgium (6.0%),
it was similar in women from both countries (Brazil: 11.5%;
Belgium: 11.8%). The severe prevalence was similar in men
(Belgium: 8.2%; Brazil: 7.8%), but much larger in Belgian
(16.6%) women compared to Brazilian (9.1%) women.
Musculoskeletal conditions were the main contributors
to moderate functional limitations in men and women
from both countries and for severe functional limitations
in Belgium. Depression and heart diseases were the main
contributors to the prevalence of severe functional limita-
tions in men and women from Brazil, respectively.
Discussion
This is the first study to compare the contribution of
chronic conditions to moderate and severe functional
limitations in a high and a middle income country, using
the extended attribution method to multinomial disability
outcomes. Although musculoskeletal conditions were
among the main contributors to the moderate and severe
prevalence of functional limitations in Belgium, this was
observed only for moderate functional limitations in
Brazil. For severe functional limitations, depression and
heart diseases contributed most in Brazil.
A smaller gender gap in the prevalence of functional
limitations was observed in Brazil than in Belgium, espe-
cially for severe functional limitations, indicating that in
Brazil the proportion of older women (age ≥ 65 years)
reporting severe difficulties/inability in feeding, bathing/
showering, or using the toilet is only slightly higher than
in men, while in Belgium this gender difference is more
pronounced. Although the explanations for the differ-
ences between the two countries are not clear, it can re-
flect: (i) differences in the question formulation in the
Table 4 Background cumulative hazard and rank of the disabling impact by age group for women. Health Interview Surveys,
Belgium, 2008 and 2013 and National Household Sample Survey, Brazil, 2008
Belgium
Rank Moderate Severe
65–74 years ≥75 years 65–74 years ≥75 years
Condition DI CI Condition DI CI Condition DI CI Condition DI CI
1 Depression 0.27 0.00; 0.61 Depression 0.14 −0.05; 0.37 Cancer 0.09 0.03; 0.15 Depression 0.73 0.42; 1.12
2 Heart diseases 0.26 −0.01; 0.75 Musculoskeletal 0.10 0.02; 0.17 Depression 0.08 0.05; 0.11 Diabetes 0.28 0.06; 0.49
3 Musculoskeletal 0.05 0.02; 0.09 Diabetes 0.08 −0.04; 0.19 Diabetes 0.03 0.02; 0.05 Heart diseases 0.18 −0.08; 0.51
4 Cancer 0.02 −0.05; 0.11 Heart diseases 0.08 −0.09; 0.30 Heart diseases 0.03 0.02; 0.05 Musculoskeletal 0.14 0.08; 0.28
5 Respiratory 0.01 −0.04; 0.09 Respiratory 0.00 −0.13; 0.10 Respiratory 0.01 −0.01; 0.03 Cancer 0.06 −0.28; 0.53
6 Diabetes 0.00 −0.05; 0.06 Cancer 0.00 −0.13; 0.20 Musculoskeletal 0.01 0.00; 0.02 Respiratory 0.00 −0.18; 0.18
– Background 0.04 0.02; 0.06 Background 0.11 0.08; 0.16 Background 0.03 0.02; 0.03 Background 0.26 0.18; 0.30
Brazil
Rank Moderate Severe
65–74 years ≥75 years 65–74 years ≥75 years
Condition DI CI Condition DI CI Condition DI CI Condition DI CI
1 Cancer 0.06 0.00; 0.12 Heart diseases 0.07 0.03; 0.10 Cancer 0.09 0.03; 0.15 Depression 0.15 0.10; 0.21
2 Heart diseases 0.05 0.03; 0.08 Diabetes 0.06 0.01; 0.09 Depression 0.08 0.05; 0.11 Cancer 0.15 0.05; 0.27
3 Depression 0.05 0.03; 0.08 Musculoskeletal 0.05 0.03; 0.08 Diabetes 0.03 0.02; 0.05 Heart diseases 0.12 0.09; 0.16
4 Diabetes 0.03 0.01; 0.05 Depression 0.05 −0.01; 0.09 Heart diseases 0.03 0.02; 0.05 Diabetes 0.06 0.02; 0.10
5 Respiratory 0.03 0.00; 0.06 Respiratory 0.00 −0.05; 0.05 Respiratory 0.01 −0.01; 0.03 Respiratory 0.06 0.00; 0.12
6 Musculoskeletal 0.03 0.01; 0.04 Cancer 0.00 −0.07; 0.08 Musculoskeletal 0.01 0.00; 0.02 Musculoskeletal 0.02 0.00; 0.05
– Background 0.05 0.05; 0.06 Background 0.13 0.11; 0.14 Background 0.03 0.02; 0.03 Background 0.12 0.11; 0.14
Heart diseases: myocardial infarction and coronary heart disease
Musculoskeletal: arthritis and back pain
Respiratory: asthma and chronic bronchitis (Brazil); and asthma, chronic bronchitis, pulmonary emphysema, and chronic obstructive pulmonary diseases (Belgium)
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surveys; (ii) gender differences in the prevalence of
chronic conditions; and (iii) cultural differences in the
interpretation in the ADL questions and in reporting
ADL limitations in the surveys [31]. A small gender dif-
ference in the prevalence of severe ADL limitations has
been previously reported in a study with data of one
Brazilian city [32].
Despite all the differences previously mentioned, a
remarkable finding is that the prevalence of moderate
(men and women) and severe (men) functional limitations
is rather similar in Belgium and Brazil. These results seem
contradictory, especially because of the differences in the
ageing process in Brazil and Belgium. The current older
adults in Brazil are exposed to the burden of chronic condi-
tions and, at the same time, are survivors of infectious dis-
eases and worse overall living conditions in their early life
[33]. Besides the cultural differences in reporting functional
limitations, the similarity in the prevalence of functional
limitations in the two countries can be related to a mortal-
ity selection during childhood in the older population in
Brazil [33]. This means that the current older individuals in
Brazil were highly selected in terms of health. This is sup-
ported by the similarity in the proportion of healthy life
years (very good, good or fair self-perceived health) at age
65 in Belgium (men: 86%; women: 78%) [34] and at age 60
in Brazil (men: 87%; women: 86%) [35] in 2013.
Conversely, a larger prevalence of severe functional
limitations was observed in women from Belgium com-
pared to Brazil. One possible explanation is the fact that
the older population living in institutions was included
in the survey in Belgium but not in Brazil. In Belgium,
6.6% of the individuals aged 65 years or older were living
in long-term care institutions in 2004 [36]. Most of these
individuals are women (78.5% in 2007) [37] and have
ADL limitations, as this is an admission requirement
[36]. Nonetheless, only 0.5% of the older individuals
were living in institutions in Brazil in 2011 [38].
Musculoskeletal conditions are the most common cause
of functional limitations [39] and they have been previously
identified as the main contributor to the disability burden
using the attribution method with different indicators in
Belgium [15, 16, 18] and other European countries [40–42].
This was also found in a previous study using the HISBe
data from 1997, 2001, 2004, and 2008 that investigated the
main contributors to mild and severe disability burden with
the attribution method using a binary outcome based on
six ADL and mobility limitations, except in men with se-
vere limitations, in which chronic respiratory diseases were
identified as the main contributor [14]. These results are in
agreement with our current findings: chronic respiratory
diseases were the second contributor to the severe preva-
lence of functional limitations in Belgian men. This can be
related to life style risk factors, such as tobacco smoking,
which are more common among older men in Belgium
[43] and to past working conditions, as approximately
10% of male labour force was related to the Belgian coal
industry [44].
In Brazil, musculoskeletal conditions were the main
contributors to moderate functional limitations, whereas
depression and heart diseases contributed most to the
severe prevalence. The attribution method has also been
previously applied to the Brazilian National Health Survey
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Fig. 2 – Age-standardized prevalence of functional limitations and absolute contribution of chronic conditions and background to moderate
and severe functional limitations. Health Interview Surveys, Belgium, 2008 and 2013 and National Household Sample Survey, Brazil, 2008. Heart
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data from 2013, where stroke was the main contributor in
men and diabetes in women [19]. Although heart diseases
were among the main contributors in women, depression
was not even significant in the model and it was excluded
from the analysis [19]. The differences in the main con-
tributors compared to the present study can be due to: (i)
different disability definition, as the previous study defined
disability based on ADL and instrumental ADL limita-
tions; (ii) no distinction between severity levels in the pre-
vious study, thus the results might have been driven by
moderate limitations, as it is more frequent than severe
disability; (iii) no adjustment for age in the previous study,
hence the results for the younger age groups (65–74 years)
may be overrepresented, as a higher proportion individ-
uals aged 65–74 years was observed in the sample studied;
and (iv) stroke was not included in the present analysis as
it was not available in the NHSSBr in 2008 and its contri-
bution was, therefore, captured by the background.
It is interesting to note that chronic respiratory diseases
were among the main contributors to the severe preva-
lence of functional limitations among men and women in
Belgium, but not in Brazil. Despite the different definition
of chronic respiratory diseases in both surveys, as in
Belgium COPD, which is an important cause of functional
limitations [45], was also included in this disease group,
another possible explanation is the lower prevalence of to-
bacco smoking observed in Brazil (men: 21.6%; women:
13.1%) [46] compared to Belgium (men: 28.0%; women:
21%) [43] among individuals aged 15 years or older in
2008. Differences in passive smoking and air pollution
between the two countries may also have contributed. In
the previous study with the 2013 Brazilian data, chronic
respiratory diseases, which included COPD, were not im-
portant contributors to the prevalence of ADL and IADL
limitations [19].
In the attribution method, the contribution of chronic
diseases to the prevalence of functional limitations depends
on the disease prevalence and the disabling impact of the
disease [11, 12]. For instance, musculoskeletal conditions
were important contributors to the prevalence of moderate
functional limitations in both countries mainly due to their
high prevalence in the populations, while depression and
heart diseases were the main contributors to severe func-
tional limitations in Brazil owing to their high disabling im-
pact and prevalence, respectively. Cancer was among the
most disabling diseases in Brazil, but due to its low preva-
lence, it was not an important contributor to the prevalence
of functional limitations. The lower prevalence of cancer in
Brazil compared to Belgium can be related to delayed diag-
nosis, resulting in shorter survival in Brazil [47].
Differences in the contributors to the prevalence of
functional limitations in Belgium and Brazil can be re-
lated to dissimilarities between the countries related to:
(i) health care access; (ii) quality of diagnosis and health
care; (iii) socioeconomic conditions; (iv) stage of epide-
miologic transition; (v) life expectancy; and (vi) preva-
lence of life style risk factors. For instance, a large
difference in the education attainment between the
study populations of the two countries was observed: in
Brazil, more than 80% of the individuals with moderate
or severe functional limitations reported no diploma or
primary education while this proportion was around
35–60% in Belgium. In a previous study with the 1997
HISBe, individuals with low education attainment
showed a higher prevalence and disabling impact for
heart diseases and stroke compared to highly educated
individuals [18].
Depression was an important contributor to the severe
prevalence of functional limitations in Brazil. Although
functional limitations were found to be short-term out-
comes of depression, which can be partly explained by
reduced physical activity and social participation in indi-
viduals with depression [48, 49], this relationship should
be carefully interpreted, as our results are based on cross-
sectional data. In other words, the causal relationship
between functional limitations and depression cannot be
established, which may have resulted in an overestimation
of the contribution of depression to the prevalence of
moderate and severe functional limitations. This temporal
bias is specially observed for depression, as an inverse
causal association has been previously reported: functional
limitations as a predictor of onset and persistence of
depression [49].
The main limitation of the attribution method is re-
lated to the use of cross-sectional data. Despite the
plausibility of the causal assumption between chronic
conditions and functional limitations, it cannot be
assessed with cross-sectional data. This may result in
incorrect attribution of disability to diseases in cases
where disability occurred before diseases [11, 12].
Although longitudinal studies are better suited to assess
the causal relationship between diseases and functional
limitations [11], no representative longitudinal data are
currently available in both countries.
The role of disease co-occurrence, which could be
captured by including two-way interactions between
diseases in the multinomial model, was not investigated
due to the limited sample size in the Belgian surveys.
The effect of disease combinations has been previously
investigated in Belgium with a binary disability outcome
[16], indicating that the co-occurrence of (i) chronic re-
spiratory diseases and depression and (ii) cardiovascular
diseases and diabetes were very disabling (highest disab-
ling impacts) but not important contributors to the
disability prevalence due to their low occurrence in the
older population in Belgium.
The use of self-reported chronic conditions can hamper
comparability between the two countries, as it is associated
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with health care access and medical diagnosis. Also, cultural
differences may have an impact in the interpretation and
the reply to questions, although most of the questions were
very similar in both surveys. An overestimation of the back-
ground contribution might have occurred due to: (i) the
lack of information about important causes of functional
limitations such as stroke and dementia, as they were not
systematically included in both surveys; and (ii) underdiag-
nosed diseases, especially in Brazil, as medical diagnose of
diseases is related to health care access. This is supported
by the higher proportion of individuals without any re-
ported disease observed in the Brazilian population with
moderate and severe functional limitations.
Although previous studies with binary disability out-
comes have shown that the contribution of diseases to the
disability prevalence differ according to educational level,
with higher disabling impacts observed among lower edu-
cated groups [18, 50], we were not able to account for it in
our analysis, due to the limited sample size of the Belgian
surveys.
Furthermore, our definition of functional limitations
included only three ADLs (eating, showering, and toileting),
as they were common to the surveys in both countries.
Nonetheless, these three ADLs cover the whole ADL
spectrum, including easy, intermediate and difficult
tasks [22–24]. Finally, the use of the pooled data of the
2008 and 2013 surveys in Belgium was necessary due to
the small sample size of the 2008 survey, which did not
allow us to fit the multinomial model. Although this
might have impacted the comparability between the re-
sults of the two countries, we expect that this impact
was minimal, as the prevalence of moderate and severe
functional limitations did not show substantial changes
between 2008 and 2013 in Belgium (Additional file 2).
The main added value of this study was the possibility
to investigate the contributors to different severity levels
of functional limitations in a high and a middle income
country, using the population-based survey data from
both countries. Despite the small differences in the for-
mulation of the questions in the two independent sur-
veys, the similarity of the surveys allowed us to compare
the results of the two countries.
Conclusions
Our study showed important differences in the main
contributors to the moderate and severe prevalence of
functional limitations in Belgium and Brazil, which can
be related to differences in disease diagnosis, health care
access and quality, socioeconomic conditions, stage of
epidemiology transition, life expectancy, and prevalence
of risk factors for chronic conditions between the two
countries. These differences should be taken into
account when comparing the main contributors to the
prevalence of functional limitations between developing
and developed countries and should also be considered
by policymakers to reduce functional limitations. For in-
stance, in Belgium strategies focusing on both prevention
and treatment of musculoskeletal conditions to delay dis-
ease progression should be targeted, as they were associated
with both moderate and severe functional limitations
mainly due their high occurrence in the Belgian older
population. In Brazil, besides musculoskeletal condi-
tions, which were also associated with moderate func-
tional limitations, depression and heart diseases should
be prioritized, as these diseases contributed most to severe
functional limitations. Therefore, strategies to reduce severe
functional limitations in Brazil should focus on prevention
of heart diseases, which presented a high prevalence, and
on the disease management and modification of the envir-
onment to make it more accessible for individuals with
depression, as it showed a high disabling impact.
Distinguishing between severity levels in functional
limitations is crucial for policymakers, as severe levels
are associated with higher dependence, long-term care,
social burden, and increased health care costs. Although
the assessment of different severity levels of functional
limitations is more informative, it should be preferred
over a binary outcome when the sample size is large
enough, especially when the prevalence of functional limita-
tions is low. Future studies should take into account educa-
tion attainment when investigating the differences in the
prevalence of functional limitations between countries. It
can also be interesting to extend the attribution method to
longitudinal data, as causality could be directly assessed,
keeping in mind that the model can become more complex,
as several transition rates (e.g between no, moderate, and
severe functional limitations) will need to be estimated.
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